Ten year experience with induction therapy in locally advanced non-small cell lung cancer (NSCLC): is clinical re-staging predictive of pathological staging?
Open Access
- 1 June 2001
- journal article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 19 (6) , 894-898
- https://doi.org/10.1016/s1010-7940(01)00697-2
Abstract
Objective: To verify if in our experience with ‘induction therapy’ in non-small cell lung cancer (NSCLC) the clinical re-staging is really predictiveKeywords
This publication has 17 references indexed in Scilit:
- Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and ImplicationsJournal of Clinical Oncology, 2000
- Role of multimodality treatment for lung cancerSeminars in Surgical Oncology, 2000
- Docetaxel (Taxotere®) in the neo-adjuvant setting in non-small-cell lung cancerAnnals of Oncology, 1999
- Concurrent radio-chemotherapy in N2 non small cell lung cancer: interim analysisEuropean Journal of Cardio-Thoracic Surgery, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIa (N2) non-small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1996
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1993
- Randomized trial of neoadjuvant therapy for lung cancer: Interim analysisThe Annals of Thoracic Surgery, 1992